Abstract

N-Acetyl-p-Aminophenol (APAP), also known as acetaminophen, is the most commonly used over-the counter analgesic and antipyretic medication. However, its overdose leads to both liver and kidney damage. APAP-induced toxicity is considered as one of the primary causes of acute liver failure; numerous scientific reports have focused majorly on APAP hepatotoxicity. Alternatively, not many works approach APAP nephrotoxicity focusing on both its mechanisms of action and therapeutic exploration. Moringa oleifera (MO) is pervasive in nature, is reported to possess a surplus amount of nutrients, and is enriched with several bioactive candidates including trace elements that act as curatives for various clinical conditions. In this study, we evaluated the nephro-protective potential of MO leaf extract against APAP nephrotoxicity in male Balb/c mice. A single-dose acute oral toxicity design was implemented in this study. Group 2, 3, 4 and 5 received a toxic dose of APAP (400 mg/kg of bw, i.p) and after an hour, these groups were administered with saline (10 mL/kg), silymarin—positive control (100 mg/kg of bw, i.p), MO leaf extract (100 mg/kg of bw, i.p), and MO leaf extract (200 mg/kg bw, i.p) respectively. Group 1 was administered saline (10 mL/kg) during both the sessions. APAP-treated mice exhibited a significant elevation of serum creatinine, blood urea nitrogen, sodium, potassium and chloride levels. A remarkable depletion of antioxidant enzymes such as SOD, CAT and GSH-Px with elevated MDA levels has been observed in APAP treated kidney tissues. They also exhibited a significant rise in pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and decreased anti-inflammatory (IL-10) cytokine level in the kidney tissues. Disorganized glomerulus and dilated tubules with inflammatory cell infiltration were clearly observed in the histology of APAP treated mice kidneys. All these pathological changes were reversed in a dose-dependent manner after MO leaf extract treatment. Therefore, MO leaf extract has demonstrated some therapeutic effectiveness against APAP-induced nephrotoxicity through enhancement of the endogenous antioxidant system and a modulatory effect on specific inflammatory cytokines in kidney tissues.

Highlights

  • Acetaminophen (APAP) is a readily available over-the-counter medication as an effective painkiller and fever suppressor

  • The pathophysiology of APAP-induced hepatotoxicity is proposed to be similar to that of APAP nephrotoxicity; here we extended our investigation on the potential nephro-protective mechanism of Moringa oleifera (MO) leaf extract against APAP-induced nephrotoxicity

  • The results of this study indicated that administration of APAP-inflicted substantial renal damage as evidenced by the elevated levels of serum creatinine, blood urea nitrogen, Na+, K+, and Cl−

Read more

Summary

INTRODUCTION

Acetaminophen (APAP) is a readily available over-the-counter medication as an effective painkiller and fever suppressor. In an APAP overdose, the supply of sulfate and glutathione get exhausted, more NAPQI is generated via CYP450 metabolism This electrophilic intermediary binds with available cellular proteins and initiate lipid peroxidation, mediated reactive oxygen species (ROS) and other free radical formation, thereby inducing oxidative stress and inflicting renal tissue damage (Isik et al 2006, Ahmad et al 2012). Silymarin has been selected as the positive control for this study, based on previous study reports due to its enhanced hepato- and renal-protective properties against APAP toxicity in mice due to its enriched antioxidative and anti-inflammatory nature (He et al 2004, Bektur et al 2013) This would pave way for further investigation on the advancement of MO leaf extract as an effective therapy for both APAP-induced nephro- and hepato-toxicity in the field of clinical / translational medication

MATERIALS AND METHODS
Trace elements of MO leaf extract
RESULTS
MO leaf extract minimizes APAP-induced nephrotoxicity in mice
DISCUSSION
CONCLUSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.